368 related articles for article (PubMed ID: 18760542)
1. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
Yeh HL; Tsai SJ
Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
[TBL] [Abstract][Full Text] [Related]
2. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
5. What is 'early onset dementia'?
Miyoshi K
Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
[TBL] [Abstract][Full Text] [Related]
6. GSK-3 inhibitors for Alzheimer's disease.
Avila J; Hernández F
Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease pathogenesis: role of aging.
Harman D
Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.
Nochlin D; van Belle G; Bird TD; Sumi SM
Alzheimer Dis Assoc Disord; 1993; 7(4):212-22. PubMed ID: 8305189
[TBL] [Abstract][Full Text] [Related]
9. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker.
Khan TK; Alkon DL
Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507
[TBL] [Abstract][Full Text] [Related]
10. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
11. Genetic study of familial cases of Alzheimer's disease.
Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
[TBL] [Abstract][Full Text] [Related]
12. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
14. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene.
Tanzi RE; St George-Hyslop PH; Haines JL; Polinsky RJ; Nee L; Foncin JF; Neve RL; McClatchey AI; Conneally PM; Gusella JF
Nature; 1987 Sep 10-16; 329(6135):156-7. PubMed ID: 2888020
[TBL] [Abstract][Full Text] [Related]
15. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.
Duering M; Grimm MO; Grimm HS; Schröder J; Hartmann T
Neurobiol Aging; 2005 Jun; 26(6):785-8. PubMed ID: 15718035
[TBL] [Abstract][Full Text] [Related]
16. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
17. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.
Nakashima H; Ishihara T; Suguimoto P; Yokota O; Oshima E; Kugo A; Terada S; Hamamura T; Trojanowski JQ; Lee VM; Kuroda S
Acta Neuropathol; 2005 Dec; 110(6):547-56. PubMed ID: 16228182
[TBL] [Abstract][Full Text] [Related]
18. Does early-onset Alzheimer disease constitute a distinct subtype? The contribution of molecular genetics.
Harvey RJ; Rossor MN
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 1():S7-13. PubMed ID: 7546599
[TBL] [Abstract][Full Text] [Related]
19. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
20. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
Swerdlow RH; Khan SM
Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
